Mitobe Y - Search Results

1

Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.

Sugata K, Yasunaga J, Mitobe Y, Miura M, Miyazato P, Kohara M, Matsuoka M. Sugata K, et al. Among authors: mitobe y. Blood. 2015 Aug 27;126(9):1095-105. doi: 10.1182/blood-2015-04-641118. Epub 2015 Jun 10. Blood. 2015. PMID: 26063164 Free article.

2

HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival.

Mitobe Y, Yasunaga J, Furuta R, Matsuoka M. Mitobe Y, et al. Cancer Res. 2015 Oct 1;75(19):4143-52. doi: 10.1158/0008-5472.CAN-15-0942. Epub 2015 Sep 17. Cancer Res. 2015. PMID: 26383166

3

HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).

Yasuma K, Yasunaga J, Takemoto K, Sugata K, Mitobe Y, Takenouchi N, Nakagawa M, Suzuki Y, Matsuoka M. Yasuma K, et al. Among authors: mitobe y. PLoS Pathog. 2016 Jan 6;12(1):e1005372. doi: 10.1371/journal.ppat.1005372. eCollection 2016 Jan. PLoS Pathog. 2016. PMID: 26735971 Free PMC article.

4

HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4(+) T cells.

Kawatsuki A, Yasunaga JI, Mitobe Y, Green PL, Matsuoka M. Kawatsuki A, et al. Among authors: mitobe y. Oncogene. 2016 Aug 25;35(34):4509-17. doi: 10.1038/onc.2015.510. Epub 2016 Jan 25. Oncogene. 2016. PMID: 26804169 Free PMC article.

5

HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation.

Sugata K, Yasunaga J, Kinosada H, Mitobe Y, Furuta R, Mahgoub M, Onishi C, Nakashima K, Ohshima K, Matsuoka M. Sugata K, et al. Among authors: mitobe y. Cancer Res. 2016 Sep 1;76(17):5068-79. doi: 10.1158/0008-5472.CAN-16-0361. Epub 2016 Jul 11. Cancer Res. 2016. PMID: 27402079

6

Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.

Naito T, Yasunaga JI, Mitobe Y, Shirai K, Sejima H, Ushirogawa H, Tanaka Y, Nakamura T, Hanada K, Fujii M, Matsuoka M, Saito M. Naito T, et al. Among authors: mitobe y. Retrovirology. 2018 Nov 6;15(1):72. doi: 10.1186/s12977-018-0454-x. Retrovirology. 2018. PMID: 30400920 Free PMC article.

7

RNA-binding protein NONO promotes breast cancer proliferation by post-transcriptional regulation of SKP2 and E2F8.

Iino K, Mitobe Y, Ikeda K, Takayama KI, Suzuki T, Kawabata H, Suzuki Y, Horie-Inoue K, Inoue S. Iino K, et al. Among authors: mitobe y. Cancer Sci. 2020 Jan;111(1):148-159. doi: 10.1111/cas.14240. Epub 2019 Dec 11. Cancer Sci. 2020. PMID: 31733123 Free PMC article.

8

PSF Promotes ER-Positive Breast Cancer Progression via Posttranscriptional Regulation of ESR1 and SCFD2.

Mitobe Y, Iino K, Takayama KI, Ikeda K, Suzuki T, Aogi K, Kawabata H, Suzuki Y, Horie-Inoue K, Inoue S. Mitobe Y, et al. Cancer Res. 2020 Jun 1;80(11):2230-2242. doi: 10.1158/0008-5472.CAN-19-3095. Epub 2020 Mar 25. Cancer Res. 2020. PMID: 32213542

9

Prostate cancer-associated lncRNAs.

Mitobe Y, Takayama KI, Horie-Inoue K, Inoue S. Mitobe Y, et al. Cancer Lett. 2018 Apr 1;418:159-166. doi: 10.1016/j.canlet.2018.01.012. Epub 2018 Jan 9. Cancer Lett. 2018. PMID: 29330107 Review.

10

Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.

Mitobe Y, Ikeda K, Sato W, Kodama Y, Naito M, Gotoh N, Miyata K, Kataoka K, Sasaki H, Horie-Inoue K, Inoue S. Mitobe Y, et al. Cancer Sci. 2020 Jul;111(7):2440-2450. doi: 10.1111/cas.14498. Epub 2020 Jun 13. Cancer Sci. 2020. PMID: 32437068 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters